 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 01/15/2021 |
$3.01 |
$4.44 |
$2.73 |
$3.85 |
19.88M | | 01/19/2021 |
$3.76 |
$4.62 |
$3.33 |
$4.33 |
4.99M | | 01/20/2021 |
$4.23 |
$4.30 |
$3.61 |
$3.86 |
1.40M | | 01/21/2021 |
$3.93 |
$3.98 |
$3.61 |
$3.72 |
678.20K | | 01/22/2021 |
$3.59 |
$3.81 |
$3.39 |
$3.67 |
585.50K |
|
|
| Acer Therapeutics is a pharmaceutical company focused on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Co.'s pipeline includes three clinical-stage candidates: EDSIVO™ (celiprolol) for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001 (a taste-masked, immediate release formulation of sodium phenylbutyrate) for the treatment of various inborn errors of metabolism, including urea cycle disorders and Maple Syrup Urine Disease; and osanetant for the treatment of induced Vasomotor Symptoms where Hormone Replacement Therapy is likely contraindicated. | |
|
Acer Therapeutics (ACER) has the following price history information. Looking back at ACER historical stock prices for the last five trading days, on January 15, 2021, ACER opened at $3.01, traded as high as $4.44 and as low as $2.73, and closed at $3.85. Trading volume was a total of 19.88M shares. On January 19, 2021, ACER opened at $3.76, traded as high as $4.62 and as low as $3.33, and closed at $4.33. Trading volume was a total of 4.99M shares. On January 20, 2021, ACER opened at $4.23, traded as high as $4.30 and as low as $3.61, and closed at $3.86. Trading volume was a total of 1.40M shares. On January 21, 2021, ACER opened at $3.93, traded as high as $3.98 and as low as $3.61, and closed at $3.72. Trading volume was a total of 678.20K shares. On January 22, 2021, ACER opened at $3.59, traded as high as $3.81 and as low as $3.39, and closed at $3.67. Trading volume was a total of 585.50K shares.
ACER Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Acer Therapeutics shares, starting with a $10,000 purchase of ACER, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/25/2011 |
|
| End date: |
01/22/2021 |
|
| Start price/share: |
$28.02 |
|
| End price/share: |
$3.67 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-86.90% |
|
| Average Annual Total Return: |
-18.39% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$1,310.49 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 01/15/2021 | $3.85 | | 01/19/2021 | $4.33 | | 01/20/2021 | $3.86 | | 01/21/2021 | $3.72 | | 01/22/2021 | $3.67 |
|
|
